Transcriptomics

Dataset Information

0

Dormant tumors circumvent tumor-specific adaptive immunity by establishing a Treg-dominated niche via DKK3


ABSTRACT: Approximately 30% of breast cancer survivors deemed ‘free of disease’ will experience locoregional or metastatic recurrence even up to 30 years post initial diagnosis, yet how residual/dormant tumor cells escape immunity elicited by the primary tumor remains unclear. We demonstrate that intrinsically dormant tumor cells are indeed recognized and lysed by antigen-specific T cells in vitro and elicit robust immune responses in vivo. However, despite close proximity to CD8+ killer T cells, dormant tumor cells themselves support early accumulation of protective FoxP3+ T regulatory cells (Tregs), which can be targeted to reduce tumor burden. These intrinsically dormant tumor cells maintain a hybrid epithelial/mesenchymal or stem-like state, which is associated with immune dysfunction, and we find the tumor-derived stem/basal gene Dickkopf WNT Signaling Pathway Inhibitor 3 (DKK3) is critical for Treg inhibition of CD8+ T cells. We also demonstrate that DKK3 promotes immune-mediated progression of proliferative tumors and is significantly associated with poor survival and immune suppression in human breast cancers. Together, these findings reveal that latent tumors can use fundamental mechanisms of tolerance to alter the T cell microenvironment and subvert immune detection. Thus, targeting these pathways, such as DKK3, may help render dormant tumors susceptible to immunotherapies.

ORGANISM(S): Mus musculus

PROVIDER: GSE240021 | GEO | 2023/11/06

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-07-30 | GSE273448 | GEO
2013-03-31 | GSE39182 | GEO
| PRJNA1001930 | ENA
2018-11-30 | GSE107403 | GEO
2017-07-22 | GSE84725 | GEO
2024-09-02 | BIOMD0000001042 | BioModels
2023-06-16 | MSV000092193 | MassIVE
2023-04-19 | PXD040957 | Pride
2018-05-05 | GSE114056 | GEO
2023-03-21 | PXD034772 | Pride